[1] Howlader N, Noone A, Krapcho M, et al., eds. SEER Cancer Statistics Review. Bethesda, MD: National Cancer Institute; 1975-2016. Available at: http://seer.cancer.gov/csr/1975-2016/. Accessed Novmber 22,2019.
[2] Rudin CM, Ismaila N, Hann CL, Malhotra N, Movsas B, Norris K, Pietanza MC, Ramalingam SS, Turrisi AT 3rd, Giaccone G. Treatment of small-cell lung cancer: American Society of Clinical Oncology Endorsement of the American College of Chest Physicians Guideline. J Clin Oncol 33 (34):4106-4111,2105.
[3] Früh M, de Ruysscher D, Popat S, et al. Small-cell lung cancer (SCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol.2013;24 Suppl 6:vi99-vi105.
[4] Jeremic B. Thoracic radiation therapy in extensive disease small cell lung Cancer. Int J Radiat Oncol Biol Phys 2015;93:79.
[5] Mansfield AS, Każarnowicz A, Karaseva N, et al. Safety and patient-reported outcomes of atezolizumab, carboplatin, and etoposide in extensive-stage small-cell lung cancer (IMpower133): a randomized phase I/III trial. Ann Oncol 2020 02;31(2).
[6] Paz-Ares L, Dvorkin M, Chen Y, et al. Durvalumab plus platinum-etoposide versus platinum-etoposide in firstline treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial. Lancet 2019, 394(10212):1929-1939
[7] Nesbit EG, Leal TA, Kruser TJ. What is the role of radiotherapy for extensive-stage small cell lung cancer in the immunotherapy era? Transl Lung Cancer Res. 2019;8(Suppl 2):S153-S162.
[8] Jeremic B, Shibamoto Y , Nikolic N, et al. Role of radiation therapy in the combined-modality treatment of patients with extensive disease small cell lung cancer: a randomized study. J Clin Oncol. 1999;17(7):2092.
[9] Slotman BJ, van Tinteren H, Praag JO, et al. Use of thoracic radiotherapy for extensive stage small-cell lung cancer: a phase 3 randomized controlled trial. Lancet. 2015;385(9962):36–42.
[10] Slotman BJ, Faivre-Finn C, van Tinteren H, et al. Which patients with ES-SCLC are most likely to benefit from more aggressive radiotherapy: A secondary analysis of the Phase III CREST trial. Lung Cancer. 2017;108:150 153.
[11] Slotman BJ, van Tinteren H, Praag JO, et al. Radiotherapy for extensive stage small-cell lung cancer - Authors' reply. Lancet. 2015;385(9975):1292-1293.
[12] Slotman BJ, van Tinteren H. Which patients with extensive stage small-cell lung cancer should and should not receive thoracic radiotherapy? Transl Lung Cancer Res. 2015;4(3):292-294.
[13] Gore EM, Hu C, Sun AY, et al. Randomized Phase II Study Comparing Prophylactic Cranial Irradiation Alone To Prophylactic Cranial Irradiation And Consolidative Extra-Cranial Irradiation For Extensive Disease Small Cell Lung Cancer (ED-SCLC): NRG Oncology RTOG 0937[J]. J Clin Oncol,2017,12(10):1561-1561.
[14] Zhu H, Zhou Z, Wang Y, et al. Thoracic radiation therapy improves the overall survival of patients with extensive-stage small cell lung cancer with distant metastasis. Cancer. 2011;117(23):5423–5431.
[15] Giuliani ME, Atallah S, Sun A, et al. Clinical outcomes of extensive stage small cell lung carcinoma patients treated with consolidative thoracic radiotherapy. Clin Lung Cancer 2011; 12: 375–79.
[16] Yee D, Butts C, Reiman A, et al. Clinical trial of post-chemotherapy consolidation thoracic radiotherapy for extensive-stage small cell lung cancer. Radiotherapy and Oncology. 2012;102(2):234–238.
[17] Wu C, Wang T, Wang J, Qu B, Wang H, Hu Y. Effect of radiotherapy on the treatment of patients with extensive stage small cell lung cancer. Genet Mol Res. 2014;13(4):8577–8585.
[18] Tian, S., Zhang, X., Jiang, R., et al. Survival Outcomes with Thoracic Radiotherapy in Extensive-Stage Small Cell Lung Cancer: A Propensity-Score Matched Analysis of the National Cancer Data Base. Clinical Lung Cancer.2019;20 (6)
[19] National Comprehensive Cancer Network.NCCN guidelines small cell lung cancer. Available at: https://www.nccn.org/professionals/physicians_qls/pdf/scl_blocks.pdf.
[20] Simone II CB, Bogart JA, Cabrera AR,, et al. Radiation therapy for small cell lung cancer: an ASTRO clinical practice guideline. Pract Radiat Oncol 2020.
[21] Fowler JF. The linear-quadratic formula and progress in fractionated radiotherapy. Br J Radiol. 1989;62(740): 679-694. doi:10.1259/0007-1285-62-740-679
[22] Tinnemans MM, Schutte B, Lenders MH, et al. Cytokinetic analysis of lung cancer by in vivo bromodeoxyuridine labelling. Br J Cancer 1993;67:1217–22.
[23] Schild SE, Bonner JA, Hillman S, et al. Results of a phase II study of high-dose thoracic radiation therapy with concurrent cisplatin and etoposide in limited-stage small-cell lung cancer (NCCTG 95-20-53).J Clin Oncol.2007 ; 25(21):3124-3129. doi:10.1200/JCO.2006.09.9606
[24]Sisenhauer EA, Therasse P , Bogaerts J, Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S, Mooney M, Rubinstein L, Shankar L, Dodd L, Kaplan R, Lacombe D, V erweij J (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45:228–247
[25] Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995;31:1341–6.
[26] Li-Ming X, Zhao LJ, Simone CB, et al. Receipt of thoracic radiation therapy and radiotherapy dose are correlated with outcomes in a retrospective study of three hundred and six patients with extensive stage small-cell lung cancer[J]. Radiother Oncol,2017,125(2):331-337.
[27] Han Gyul Yoon, Jae Myoung Noh, Yong Chan Ahn, Dongryul Oh, Hongryull Pyo, Haeyoung KimHigher thoracic radiation dose is beneficial in patients with extensive small cell lung cancer. Radiat Oncol J 2019;37(3):185-192
[28] Luo J, Xu L, Zhao L, et al. Timing of thoracic radiotherapy in the treatment of extensive-stage small-cell lung cancer: important or not [J].Radiat Oncol,2017,12(1):42.
[29] Luan Z., Wang Z., Huang W., Zhang J., Dong W., Zhang W., YI, Y. (2015). Efficacy of 3D conformal thoracic radiotherapy for extensive-stage small-cell lung cancer: A retrospective study. Experimental and Therapeutic Medicine, 10(2), 671–678.
[30] Foster, N. R., Mandrekar, S. J., Schild, S. E., Nelson, G. D., Rowland, K. M., Deming, R. L.,Adjei, A. A. (2009). Prognostic factors differ by tumor stage for small cell lung cancer. Cancer, 115(12), 2721–2731. doi:10.1002/cncr.24314
[31]Hong S, Cho BC, Choi HJ, Jung M, Lee SH, Park KS, Kim SK, Kim JH,.Prognostic Factors in Small Cell Lung Cancer: A New Prognostic Index in Korean Patients. Oncology, 2010;79:293–300
[32] Nakazawa K, Kurishima K, Tamura T, Kagohashi K, Ishikawa H, Satoh H, et al. Specific organ metastases and survival in small cell lung cancer. Oncol Lett. 2012; 4:617–620.
[33] Ren Y, Dai C, Zheng H et al. Prognostic effect of liver metastasis in lung cancer patients with distant metastasis. Oncotarget 7(33), 53245(2016).
[34] Cai H, Wang H, UZ, el al.The prognostic analysis of different metastatic patterns in extensive-stage small cell lung cancer patients: A large population-based study[J].Future 0ncol,2018,14 (14):1397-1407.
[35] Qin T, Zhou N, Zeng YD, et al. Benefit from thoracic radiotherapy in patients with extensive-disease small-cell lung cancer with elevated lactate dehydrogenase. Onco Targets Ther 2016;9; 1095-1103.
[36] Zhang Q, Tang X, Zhang ZF, et al. Nicotine induces hypoxia-inducible factor-1alpha expression in human lung cancer cells via nicotinic acetylcholine receptor-mediated signaling pathways. Clin Cancer Res 2007;13(16):4686–4694.
[37] George J, Lim JS, Jang SJ, et al. Comprehensive genomic profiles of small cell lung cancer[J]. Nature, 2015, 524(7563):47-53.
[38] Fearon, K., Strasser, F., Anker, S. D.et al. (2011). Definition and classification of cancer cachexia: an international consensus. The Lancet Oncology, 12(5), 489–495.
[39] Menon H, Ramapriyan R, Cushman TR, et al: Role of Radiation Therapy in Modulation of the Tumor Stroma and Microenvironment. Front Immunol 10:193, 2019
[40] Demaria S, Golden EB, Formenti SC: Role of Local Radiation Therapy in Cancer Immunotherapy. JAMA Oncol 1:1325-32, 2015
[41] Wilkins A, McDonald F, Harrington K, Melcher A. Radiotherapy enhances responses of lung cancer to CTLA-4 blockade. J Immunother Cancer. 2019;7(1):64
[42] Welsh JW, Heymach JV, Chen D, et al. Phase I trial of pembrolizumab and radiation therapy after induction chemotherapy for extensive-stage small cell lung cancer. J Thorac Oncol. 2020;15(2):266–73